Net Cash Provided by (Used in) Operating Activities |
-158K |
USD |
+50.1% |
Q1 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
26M |
shares |
-94.8% |
Q3 2023 |
Q3 2023 |
Common Stock, Shares, Issued |
5M |
shares |
0% |
Q2 2023 |
Q2 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-158K |
USD |
+50.1% |
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
120K |
USD |
-85.7% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Valuation Allowance |
270K |
USD |
+93.4% |
Q4 2023 |
FY 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2023 |
Q3 2023 |
Deferred Tax Assets, Gross |
270K |
USD |
+93.4% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Q4 2023 |
FY 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
0 |
USD |
|
Q2 2023 |
Q2 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2023 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2023 |
FY 2023 |